Free Trial

Versor Investments LP Grows Holdings in Integral Ad Science Holding Corp. $IAS

Integral Ad Science logo with Business Services background

Key Points

  • Versor Investments LP increased its holdings in Integral Ad Science Holding Corp. by 374.6%, owning 63,600 shares worth approximately $513,000 by the end of the first quarter.
  • Integral Ad Science's stock saw a 3.5% decline recently, with a market capitalization of $1.49 billion and a recorded 52-week range of $6.26 to $13.62.
  • After reporting earnings that surpassed estimates, Integral Ad Science has an average price target of $13.55 from analysts, with many providing a "Moderate Buy" rating for the stock.
  • Looking to export and analyze Integral Ad Science data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Versor Investments LP lifted its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 374.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 63,600 shares of the company's stock after buying an additional 50,200 shares during the quarter. Versor Investments LP's holdings in Integral Ad Science were worth $513,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. DekaBank Deutsche Girozentrale purchased a new stake in Integral Ad Science in the 1st quarter valued at $42,000. State of Wyoming acquired a new position in Integral Ad Science in the 4th quarter valued at $51,000. Alta Fox Capital Management LLC acquired a new position in Integral Ad Science in the 4th quarter valued at $61,000. Virtu Financial LLC acquired a new position in Integral Ad Science in the 1st quarter valued at $87,000. Finally, Teacher Retirement System of Texas acquired a new position in Integral Ad Science in the 1st quarter valued at $96,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

Analyst Ratings Changes

IAS has been the topic of a number of recent analyst reports. Barclays upped their price target on shares of Integral Ad Science from $9.00 to $10.00 and gave the stock an "equal weight" rating in a research note on Friday, August 8th. Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Raymond James Financial lowered their price target on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Finally, Stifel Nicolaus upped their price target on shares of Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $13.55.

View Our Latest Report on IAS

Integral Ad Science Stock Down 2.8%

Shares of Integral Ad Science stock traded down $0.26 on Monday, hitting $8.99. The company's stock had a trading volume of 696,775 shares, compared to its average volume of 908,896. The company has a market capitalization of $1.49 billion, a P/E ratio of 26.44, a price-to-earnings-growth ratio of 1.34 and a beta of 1.57. The firm has a fifty day moving average price of $8.39 and a 200-day moving average price of $8.39. Integral Ad Science Holding Corp. has a 52-week low of $6.26 and a 52-week high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. The company had revenue of $149.20 million for the quarter, compared to analyst estimates of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts expect that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Insider Transactions at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 14,904 shares of the company's stock in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total value of $123,852.24. Following the transaction, the chief executive officer directly owned 379,316 shares in the company, valued at approximately $3,152,115.96. This represents a 3.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last 90 days, insiders have sold 35,073 shares of company stock valued at $289,641. 2.00% of the stock is currently owned by corporate insiders.

Integral Ad Science Company Profile

(Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Read More

Institutional Ownership by Quarter for Integral Ad Science (NASDAQ:IAS)

Should You Invest $1,000 in Integral Ad Science Right Now?

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines